8-K current report · filed Feb 25, 2026

LifeStance Health Group, Inc. (LFST) 8-K Current Report: February 25, 2026

Item 2.02Item 5.02Item 7.01Item 8.01LFST overview

Short answer

LifeStance Health Group, Inc. (LFST) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events). Q4 and full year 2025 earnings results released Feb 25, 2026.

LifeStance Health Group, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q4 and full year 2025 earnings results released Feb 25, 2026
  • Full financial details in Exhibit 99.1 press release: key figures not disclosed in filing body
  • LFST operates outpatient mental health clinics; results cover period ended Dec 31, 2025

Item 5.02 · Departure/Election of Directors or Officers

  • Kenneth Burdick stepping down as Executive Chairman → non-executive Chairman effective March 16, 2026
  • Post-transition comp: $200K annual cash retainer + ~$500K annual RSU grant as non-executive chair
  • Transition explicitly not tied to any disagreement with management or Board
  • Shift reduces Burdick's operational influence; signals possible leadership structure change at the top

Item 7.01 · Regulation FD Disclosure

  • Supplemental slide deck filed as Exhibit 99.2: primary source for any new operational or financial data disclosed under Reg FD
  • Reg FD filing ensures institutional and retail investors receive material information simultaneously: watch Exhibit 99.2 for guidance, metrics, or strategic updates

Item 8.01 · Other Events

  • Board approved $100M share repurchase program on Feb 24, 2026
  • No obligation to repurchase any specific amount: purely discretionary and open-ended
  • Buybacks executable via open market, private transactions, ASR programs, or block purchases
  • Signal of management confidence in valuation; returns capital to shareholders while reducing share count

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other LifeStance Health Group, Inc. 8-K filings

Get the next LFST 8-K as it lands

Follow LFST for push alerts, or ask the research agent what this filing means.